Evidence map›Paper›PMID 41023402›Full record

ArticleEye (London, England)2025

Microplastics identified in commercial over-the-counter lubricant eyedrops.

Julia Jaeger, Matthew Burke, Duoduo Wu, Emily Ern-Min Curren, Sandric Chee Yew Leong, Robert Symons, Blanche Xiao Hong Lim, Xinyi Su, Jodhbir Singh Mehta, Andri Kartasasmita Riau and 1 more

Abstract read
In one paragraph

Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julia JaegerEurofins Environment Testing Australia & New Zealand, Dandenong South, VIC, Australia.
Matthew BurkeEurofins Environment Testing Australia & New Zealand, Dandenong South, VIC, Australia.
Duoduo WuDepartment of Ophthalmology, National University Health System, Singapore, Singapore.ORCID http://orcid.org/0000-0002-2247-0949
Emily Ern-Min CurrenSt. John's Island National Marine Laboratory, Tropical Marine Science Institute, National University of Singapore, Singapore, Singapore.
Sandric Chee Yew LeongSt. John's Island National Marine Laboratory, Tropical Marine Science Institute, National University of Singapore, Singapore, Singapore.
Robert SymonsEurofins Environment Testing Australia & New Zealand, Girraween, NSW, Australia.
Blanche Xiao Hong LimDepartment of Ophthalmology, National University Health System, Singapore, Singapore.
Xinyi SuDepartment of Ophthalmology, National University Health System, Singapore, Singapore.
Jodhbir Singh MehtaSingapore Eye Research Institute, Singapore, Singapore.ORCID http://orcid.org/0000-0001-6362-4898
Andri Kartasasmita RiauSingapore Eye Research Institute, Singapore, Singapore.
Chris Hong Long LimDepartment of Ophthalmology, National University Health System, Singapore, Singapore. chrislimmd@gmail.com.ORCID http://orcid.org/0000-0003-2219-3184

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is increasing evidence that microplastics exert harmful effects on human health and on the ocular surface. This pilot study aims to investigate if microplastic particles are present in commonly used eyedrops in single-use plastic vials.

methodsSix commonly used commercial tear-replacement solutions available without a doctor's prescription were tested (Brands A-F). All brands of eyedrops were analysed visually using light microscopy and the number of microplastic particles were manually counted. These were further analysed using the Agilent 8700 Laser Direct Infrared (LDIR) chemical imaging system.

resultsAll eyedrops analysed contained microplastics. The number of particles identified using light microscopy ranged between 15 (Brand E) to >18,000 (Brand F). In total, nine types of microplastics were identified with LDIR - polyethylene, polypropylene, polystyrene, polyvinylchloride, polyethylene terephthalate, polycarbonate, polymethylmethacrylate, polyamide and polyurethane.

conclusionsThis study provides the most extensive quantification of microplastic contamination in commercial eyedrops to date, highlighting a major, under-recognised source of ocular exposure. These particles may arise from secondary degradation of plastic vials during production, transportation, storage, or during instillation, or introduced from other sources during production and represent a major source of exposure to the ocular surface, especially among patients who require chronic instillation of eyedrops.

Indexed as

Drug ContaminationLubricant Eye DropsMicroplasticsNonprescription DrugsDrug PackagingHumansPilot ProjectsPlasticsLubricant Eye DropsMicroplasticsNonprescription DrugsPlastics

Identifiers

PMID41023402
PMCPMC12623499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.